Aims/Objectives
Our objective was to compare both strategies in terms of non-inferiority.
Method
A prospective, randomised controlled trial was performed. Primary end-point was demonstrating noninferiority of miniplegia versus intermittent 4:1 blood cardioplegia in elective aortic valve replacement. For sample size calculation, a maximum increase +15% in mean peak postoperative troponin T was considered non-inferior (Δ = +474.24 ng/L). Power was 0.9, and α < 0.05 was considered statistically significant. Secondary end-points were differences in troponin curve, reperfusion and postoperative rhythm, haematocrit, use of inotropic and vasopressor drug support, ICU stay, and postoperative evolution.
Results 66 patients were enrolled and randomised. There were no significant differences in baseline and preoperative variables. Peak troponin T in miniplegia group was noninferior to blood cardioplegia group (p = 0.036). Patients in the miniplegia group showed a higher incidence of spontaneous sinus rhythm after myocardial ischemia (18/33, 54.5% versus 8/33, 24.2%, p = 0.005) and fewer patients required defibrillation (9/33, 27.7% versus 21/ 33, 63.6%, p = 0.03) for ventricular reperfusion arrhythmias. Postoperatively, there were no differences in troponin T release, inotropic and vasopressor drug support, ICU stay, and postoperative mortality.
Discussion/Conclusion
Miniplegia used as myocardial protection in elective aortic replacement is non-inferior to blood cardioplegia. Preferential return to sinus rhythm and lower incidence of reperfusion arrhythmias in the miniplegia group could reflect a better myocardial protection during cardioplegic arrest. Ease of administration and inexpensive use of miniplegia are additional benefits. Bernabeu et al. Journal of Cardiothoracic Surgery 2015, 10(Suppl 1):A60 http://www.cardiothoracicsurgery.org/content/10/S1/A60
